<?xml version="1.0" encoding="UTF-8"?><Articles><Article><id>730</id><JournalTitle>PHARMACOECONOMIC ANALYSIS OF END STAGE RENAL  DISEASED PATIENTS UNDERGOING HEMODIALYSIS</JournalTitle><Abstract>The increased prevalence of end stage renal disease (ESRD) in India and the treatment options are dialysis or kidney 
transplantation.  The  availability  and  affordability  are  two  important  issues  in  treatment  of  ESRD.  Hemodialysis  (HD)  is 
inaccessible  and  not  affordable  by  majority  of  population  in  India.   To  assess  the  direct  and  indirect  cost  of  hemodialysis 
patients.  This  was  a  prospective,  observational  and  interventional  study  conducted  for  5  months  period  in  a  secondary  care 
hospital. Patients undergoing hemodialysis were selected for the study. A 25 members undergoing hemodialysis were selected 
and the data was obtained along with cost details of 1025 sessions were studied. Health cost analyzed which includes medical 
(dialysis, erythropoietin, medications and investigations) and nonmedical costs (wages, food and transportation). The total cost 
per  session  was  found  to  be  4265,  total  1025  sessions  were  studied.  In  that  52%  contributes  direct  medical  costs,  19% 
contributes  non-medical  costs  and  29%  contributes  indirect  medical  costs,  since  the  patients  were  paying  from  their  own 
pockets only the middle class people can undergo Hemodialysis.  The health cost of treating a patient on HD in India is around 
Rupees 10,000-12,000 per month in subsidized dialysis units, and in private hospitals the health cost of treating a patient is 
around Rupees 20,000 and 30,000. This study concludes that medical cost spent more than other cost in patients undergoing 
hemodialysis units</Abstract><Email>arunchandroby@gmail.com</Email><articletype>Research</articletype><volume>7</volume><issue>3</issue><year>2016</year><keyword>Hemodialysis,End Stage Renal Disease,Erythropoietin,Pharmacoeconomic,Cost analysis</keyword><AUTHORS>Mahendra kumar BJ,Arun Chand Roby Kanamala,Mary Prasanna kumari B,Hussain Sk</AUTHORS><afflication>Dept. of Pharmacy Practice, Vikas Institute of Pharmaceutical Sciences, Rajahmundry, Andhra Pradesh, India,Dept. of Pharmacy Practice, Vikas Institute of Pharmaceutical Sciences, Rajahmundry, Andhra Pradesh, India,Dept. of Pharmacy Practice, Vikas Institute of Pharmaceutical Sciences, Rajahmundry, Andhra Pradesh, India,Dept. of Pharmacy Practice, Vikas Institute of Pharmaceutical Sciences, Rajahmundry, Andhra Pradesh, India</afflication></Article></Articles>